When a man reaches 60, his risk of experiencing an enlarged prostate climbs to one in two—and by 80, the odds stretch to four in five. Yet for decades, those facing the persistent urge to urinate at night, the weak stream, the incomplete relief, have had limited options: endure it or submit to conventional surgery. Now the Society of Interventional Radiology has published new guidance that opens a different door entirely.
Prostatic artery embolization, or PAE, represents a genuine shift in how doctors can approach benign prostatic hyperplasia, the medical term for an enlarged prostate. Rather than cutting or resecting tissue through a scope—the traditional approach known as transurethral resection of the prostate—PAE takes a far less invasive path. The procedure blocks the blood vessels feeding the enlarged tissue, allowing it to shrink without the knife. For patients tired of waking multiple times each night or struggling with the distressing combination of urinary urgency, weak flow, and incomplete emptying, the difference in recovery time and risk profile can be transformative.
The updated guidance, published in the Journal of Vascular and Interventional Radiology to mark the beginning of Men's Health Month in June, represents the culmination of new evidence accumulated since the Society's 2019 consensus statement. What has emerged is compelling enough that the American Urologic Association now recognizes PAE as a viable treatment option. The document itself serves as a roadmap for healthcare providers, spelling out the clinical evaluation of patients, the imaging needed before the procedure, and how to tailor treatment plans to each individual's diagnosis.
This matters because enlarged prostate affects millions of men silently—or rather, noisily and disruptively. The condition obstructs the bladder and creates symptoms that ripple outward into daily life in ways people rarely discuss openly. Disrupted sleep means reduced productivity. Urgency and frequency sap confidence and limit social participation. Sexual dysfunction and depression often follow. For men who value quality of life, these are not trivial concerns.
"Prostatic artery embolization offers men a minimally invasive, effective treatment option for enlarged prostate that can significantly improve urinary symptoms while reducing the risks and recovery time associated with traditional surgery," said Saher S. Sabri, MD, FSIR, President of the Society of Interventional Radiology. His emphasis on a "team-based approach to care" reflects something equally important: the guidance doesn't position PAE as a replacement for all treatments, but as a durable option that expands choice.
What makes this guidance significant is the rigor behind it. The document emerges from systematic review of emerging evidence, not marketing enthusiasm. It provides evidence-based standards for who qualifies as a candidate, how to prepare them, and what outcomes to expect. For a treatment to cross from promising innovation into standard practice, it needs this kind of institutional backing and clarity.
As men age and their prostates grow—an utterly biological fact of life for millions—having multiple, well-understood pathways forward is medicine working as it should. Prostatic artery embolization now stands alongside traditional surgery as a documented, vetted option. For those facing years of nightly disruption, that expanded choice is genuine progress.